Endothelial progenitor cells: Are they displaying a function in autoimmune disorders?

Area of Science:

• Cardiovascular Biology
• Immunology
• Regenerative Medicine

Background:

• Endothelial progenitor cells (EPCs) originate from bone marrow and differentiate into mature endothelial cells (ECs).
• EPCs contribute to neovascularization, exhibit colony-forming capacity, and play a role in endothelial repair.
• Circulating EPCs are implicated in endothelial damage associated with cardiovascular and autoimmune diseases.

Purpose of the Study:

• To review the function of EPCs in the context of autoimmune disorders.
• To expand upon existing research focused on EPCs in Systemic Sclerosis.
• To explore the diagnostic and therapeutic potential of EPCs in broader autoimmune conditions.

Main Methods:

• Literature review of studies investigating EPCs in autoimmune diseases.
• Analysis of research on EPCs' role in endothelial damage and repair mechanisms.
• Synthesis of findings related to EPCs' involvement in systemic autoimmunity.

Main Results:

• EPCs are involved in endothelial damage and repair processes in various autoimmune conditions.
• Altered EPC function and numbers are observed in several autoimmune disorders.
• EPCs hold potential for predicting disease outcomes and therapeutic interventions.

Conclusions:

• EPCs are significant biomarkers for endothelial dysfunction in autoimmune diseases.
• Further research into EPCs could lead to novel therapeutic strategies for autoimmune disorders.
• Understanding EPC behavior is critical for managing autoimmune-related cardiovascular complications.